Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Accumulated Depreciation (2019)

Historic Accumulated Depreciation for Marker Therapeutics (MRKR) over the last 1 years, with Q4 2019 value amounting to $105000.0.

  • Marker Therapeutics' Accumulated Depreciation changed N/A to $105000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $105000.0, marking a year-over-year change of. This contributed to the annual value of $105000.0 for FY2019, which is N/A changed from last year.
  • Latest data reveals that Marker Therapeutics reported Accumulated Depreciation of $105000.0 as of Q4 2019.
  • Marker Therapeutics' 5-year Accumulated Depreciation high stood at $105000.0 for Q4 2019, and its period low was $40000.0 during Q2 2019.